NeurologyOnline.net

Neurology Xagena

Search results for "Acute ischemic stroke"

Patient enrollment in the phase 3 trial of ReoPro ( Abciximab ) for the treatment of acute ischemic stroke has been permanently discontinued. Based on careful review of the data and the observed be ...


Researchers at the University of Pittsburgh report a high level of effectiveness in re-opening completely blocked internal carotid arteries ( ICA ) as late as two to three days after acute stroke symp ...


The SAINT I ( Stroke Acute Ischemic NXY-059 Treatment ) trial, published in the New England Journal of Medicine, has shown that NXY-059 is a promising drug for the treatment of acute ischemic stroke. ...


Erratic blood pressure during the first hours after a stroke dramatically lowers the chances of survival. The study is published in the journal Neurology. The researchers studied 71 emergency r ...


Among patients who have had an ischemic stroke, use of HMG-CoA reductase inhibitors ( cholesterol-lowering medications ) is not associated with subsequent intracerebral hemorrhage.After stroke or tran ...


The benefits of intravenous tissue plasminogen activator ( tPA ) in patients with acute ischemic stroke are time dependent and guidelines recommend a door-to-needle ( DTN ) time of 60 minutes or less. ...


Although the benefit of reducing blood pressure for primary and secondary prevention of stroke has been established, the effect of antihypertensive treatment in patients with acute ischemic stroke is ...


A research presented at the International Stroke Conference ( ISC ) and published in The New England Journal of Medicine ( NEJM ) found that the addition of the Solitaire Device stent thrombectomy pro ...


Runs of premature atrial complexes ( PACs ) are common in stroke patients and perceived to be clinically insignificant, but their prognostic significance is unclear. A study has investigated the ass ...